Clients
Latest News

iMiners gets rave reviews at the National Investor Relations Institute (NIRI) Annual Conference, San Diego, June 8-11 2008
Factsheet

443,021 releases categorized
from 6,500+ public companies
issued since April 1st 2006

Next Steps

Contact Me

For immediate assistance, call
Mike O’Brien at 925.984.2078
Overview
Founded in June 2005, iMiners, Inc. is changing the rules in search for how investors access relevant information, quickly. We have categorized every press release issued since April 1, 2006, by 6,500+ US public companies trading on the NASDAQ, NYSE and AMEX. Please click here for a complete list of our 10 major categories and 69 subcategories. Our proprietary database currently contains over 400,000 fully categorized releases and is growing by about 750 releases each day. iMiners is leveraging this unique database to provide new and innovative products for investor relations and public relations. Our solutions include:

Press Releases By Type is a ready-to-install module that can quickly be integrated with any company IR or News page. Press Releases By Type automatically displays a company’s press releases in one of 10 major categories for quick retrieval by visitors.

Event Charts are unique stock charts that plot all of a company’s news releases on the chart via icons which represent each of the 10 major categories. Event Charts give investors deeper context and insight into how different types of news can potentially impact a company’s stock price.

PR Cycle is the industry’s first and only Software-as-a-Service (SaaS) solution for PR and IR professionals to research and draft press releases. PR Cycle is powered by iMiners’ proprietary reference library of press releases issued by over 6,500 companies, and growing at the rate of 750 releases daily. Each press release is categorized and indexed into one of ten major categories and 69 subcategories for quick search.

eShareholderForum is the industry’s first and only turnkey solution to help any company with quickly setting up a company-sponsored electronic shareholder forum. eShareholderForum contains 4 major components: Message boards, blog, Q&A, and polling.

iMiners Data Feeds are available to any investing site that wants to drive more traffic, keep visitors longer, and keep them coming back because of a positive user experience. Please click here to read the Comtex partnership announcement.

We will continue to launch products that will leverage our growing proprietary database of categorized releases. These plans include a comprehensive institutional investor portal that will provide access to unique tools, and proprietary algorithms for event impact, correlation, and prediction.

Information is power, especially on Wall Street, and iMiners will continue to revolutionize the search process for relevant actionable information akin to finding the proverbial "needle in the haystack."
We Mine IT, So You Can Find IT!
iMiners, Inc. categorizes 750+ press releases daily by 6,500+ US public companies into one of the following 10 major and 69 sub categories.

Awards & Recognition Product Award Company Award Employee Award Patent Award General Conference Call & Meetings Analyst Meeting Earnings Conference Call Investor Conference Call Customer Meeting Shareholder Meeting Investor Meeting General Corporate Surveys Charity & Educational Giving Index Change SOX Employee Stock Option Plan Tax & Audit Infrastructure Credit General Customer & Partnerships Partnership & Joint Marketing Customer Win Customer Lost Success Story Promotions General Financial Dividend Forward or Reverse Split Share Buyback Restatement Results Secondary Offering Pre-announcement Update General Industry Events Trade Shows Conferences & Conventions User Group Company Sponsored General Legal Patent Infringement Class Action Settlement SEC Investigation FTC General Management Changes Addition Retired Terminated Promoted Compensation Reorganization GeneralM&A Merger Acquisition Hostile Takeover Rumor Spinoff General Products & Services New Product Updates & Upgrades FDA Approval FDA Rejection FDA Investigation Research Product Defect European Approval General.